Zucchi, Elisabetta
 Distribuzione geografica
Continente #
NA - Nord America 3.469
AS - Asia 2.937
EU - Europa 1.825
SA - Sud America 470
AF - Africa 72
OC - Oceania 6
Totale 8.779
Nazione #
US - Stati Uniti d'America 3.357
SG - Singapore 942
CN - Cina 859
IT - Italia 637
BR - Brasile 346
VN - Vietnam 314
HK - Hong Kong 287
GB - Regno Unito 234
SE - Svezia 158
DE - Germania 152
KR - Corea 132
FI - Finlandia 126
RU - Federazione Russa 109
FR - Francia 102
ID - Indonesia 80
IN - India 72
NL - Olanda 54
AR - Argentina 48
CA - Canada 45
BD - Bangladesh 41
LT - Lituania 38
MX - Messico 32
IQ - Iraq 31
IE - Irlanda 27
BG - Bulgaria 26
PL - Polonia 26
CZ - Repubblica Ceca 25
JP - Giappone 25
ES - Italia 23
TR - Turchia 21
ZA - Sudafrica 21
EC - Ecuador 19
AT - Austria 18
CO - Colombia 18
UA - Ucraina 18
UZ - Uzbekistan 16
SA - Arabia Saudita 14
AE - Emirati Arabi Uniti 12
MY - Malesia 12
CH - Svizzera 11
MA - Marocco 11
VE - Venezuela 11
EG - Egitto 10
PK - Pakistan 10
CL - Cile 9
TN - Tunisia 9
TW - Taiwan 9
JM - Giamaica 8
KE - Kenya 7
PH - Filippine 7
AZ - Azerbaigian 6
BE - Belgio 6
JO - Giordania 6
RO - Romania 6
UY - Uruguay 6
CR - Costa Rica 5
LB - Libano 5
PY - Paraguay 5
TH - Thailandia 5
AU - Australia 4
BH - Bahrain 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
IL - Israele 4
OM - Oman 4
PA - Panama 4
PE - Perù 4
TT - Trinidad e Tobago 4
DK - Danimarca 3
DZ - Algeria 3
GR - Grecia 3
HN - Honduras 3
IR - Iran 3
LV - Lettonia 3
NO - Norvegia 3
NP - Nepal 3
PS - Palestinian Territory 3
SN - Senegal 3
AL - Albania 2
BB - Barbados 2
BZ - Belize 2
CY - Cipro 2
ET - Etiopia 2
HR - Croazia 2
KH - Cambogia 2
MK - Macedonia 2
MT - Malta 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
AO - Angola 1
DJ - Gibuti 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
IS - Islanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
Totale 8.768
Città #
Singapore 609
Santa Clara 521
Ashburn 496
Hefei 364
Hong Kong 285
Fairfield 255
San Jose 224
Chandler 208
Beijing 133
Seoul 124
London 109
Ho Chi Minh City 91
Woodbridge 90
Helsinki 89
Nyköping 88
Seattle 85
Houston 84
Los Angeles 84
Modena 78
Hanoi 71
Milan 70
Cambridge 69
Wilmington 68
Council Bluffs 65
The Dalles 62
Jakarta 60
Munich 54
Chicago 53
New York 52
Southend 51
Bologna 38
Rome 37
San Diego 36
Shanghai 32
Ann Arbor 31
Lauterbourg 31
Moscow 30
Buffalo 29
Dearborn 28
São Paulo 27
Orem 26
Hillsboro 25
Sofia 25
Frankfurt am Main 24
Princeton 22
Turku 21
Warsaw 21
Bremen 20
Da Nang 20
Kent 20
Tokyo 20
Amsterdam 17
Lappeenranta 15
Dallas 14
Montreal 14
Atlanta 13
Brno 13
Mexico City 13
Phoenix 13
Tashkent 13
Dublin 12
Jacksonville 12
Reggio Emilia 12
Toronto 12
City of London 11
Manchester 11
Vienna 11
Johannesburg 10
Olomouc 10
Poplar 10
Redondo Beach 10
Ankara 9
Biên Hòa 9
Chennai 9
Florence 9
Haiphong 9
Hangzhou 9
Nuremberg 9
Rio de Janeiro 9
Salt Lake City 9
Turin 9
Bari 8
Denver 8
Eugene 8
New Delhi 8
Tampa 8
Brasília 7
Bắc Ninh 7
Guarulhos 7
Norwalk 7
Parma 7
Quito 7
Riyadh 7
Verona 7
Boardman 6
Brooklyn 6
Buenos Aires 6
Calcinaia 6
Guangzhou 6
Montevideo 6
Totale 5.723
Nome #
Riluzole and other prognostic factors in ALS: a population-based registry study in Italy 323
Proteostasis and ALS: Protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS) 292
Environmental and Occupational Risk Factors of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study 289
Epidemiological, Clinical and Genetic Features of ALS in the Last Decade: A Prospective Population-Based Study in the Emilia Romagna Region of Italy 288
High‐frequency motor rehabilitation in amyotrophic lateral sclerosis: a randomized clinical trial 285
Post-infectious sensory neuropathy with anti-GT1a and GQ1b antibodies associated with cold urticaria 285
Cerebrospinal Fluid Neurofilaments May Discriminate Upper Motor Neuron Syndromes: A Pilot Study 276
Clinical and Lifestyle Factors and Risk of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study 265
Predictors for progression in amyotrophic lateral sclerosis associated to SOD1 mutation: insight from two population-based registries 244
Pearls & Oy-sters: Paroxysmal dysarthria-ataxia syndrome: Acoustic analysis in a case of antiphospholipid syndrome 244
Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis: Clinical Protocol and Evaluation of Microbiota Immunity Axis 242
FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis 224
Clinical features and outcomes of the flail arm and flail leg and pure lower motor neuron MND variants: A multicentre Italian study 224
Duplication of exons 15 and 16 in Matrin-3: a phenotype bridging amyotrophic lateral sclerosis and immune-mediated disorders 214
Colchicine treatment in amyotrophic lateral sclerosis: safety, biological and clinical effects in a randomized clinical trial 208
SerpinA1 levels in amyotrophic lateral sclerosis patients: An exploratory study 198
Reply to comment on “environmental and occupational risk factors of amyotrophic lateral sclerosis: A population-based case-control study” 198
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis 195
Insight into Elderly ALS Patients in the Emilia Romagna Region: Epidemiological and Clinical Features of Late-Onset ALS in a Prospective, Population-Based Study 185
A novel p.N66T mutation in exon 3 of the SOD1 gene: report of two families of ALS patients with early cognitive impairment 184
Case report: p.Glu134del SOD1 mutation in two apparently unrelated ALS patients with mirrored phenotype 181
Amyotrophic lateral sclerosis stratification: unveiling patterns with virome, inflammation, and metabolism molecules 181
Effect of tauroursodeoxycholic acid on survival and safety in amyotrophic lateral sclerosis: a retrospective population-based cohort study 181
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study. 172
Factors predicting disease progression in C9ORF72 ALS patients 171
Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers 169
A Variant in TBCD Associated with Motoneuronopathy and Corpus Callosum Hypoplasia: A Case Report 162
CSF Heavy Neurofilament May Discriminate and Predict Motor Neuron Diseases with Upper Motor Neuron Involvement 162
The association between lifelong personality and clinical phenotype in the FTD-ALS spectrum 159
Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data 154
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial 153
The gut microbiota-immunity axis in als: A role in deciphering disease heterogeneity? 152
G507D mutation in FUS gene causes familial amyotrophic lateral sclerosis with a specific genotype-phenotype correlation. 146
Multifaceted superoxide dismutase 1 expression in amyotrophic lateral sclerosis patients: a rare occurrence? 143
Young Onset Alzheimer’s Disease Associated with C9ORF72 Hexanucleotide Expansion: Further Evidence for a Still Unsolved Association 143
Trends in Hospital Admissions for Patients with Amyotrophic Lateral Sclerosis: Insights from a Retrospective Cohort Study in a Province in Northern Italy 142
Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis 140
Reduced levels of neurosteroids in cerebrospinal fluid of amyotrophic lateral sclerosis patients 135
Neurodegenerative and neuroinflammatory changes in SOD1-ALS patients receiving tofersen 132
Phenotypical Characterization of C9ALS Patients from the Emilia Romagna Registry of ALS: A Retrospective Case–Control Study 130
Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis 127
Exploring the Role of Diabetes in ALS: A Population-Based Cohort Study 120
Psychiatric Symptoms in Amyotrophic Lateral Sclerosis: Beyond a Motor Neuron Disorder 120
The landscape of cognitive impairment in superoxide dismutase 1-amyotrophic lateral sclerosis 118
Trapianto di microbiota fecale nella Sclerosi Laterale Amiotrofica: effetti clinici e biologici di un trial clinico randomizzato 101
Withdrawal of mechanical ventilation in amyotrophic lateral sclerosis patients: a multicenter Italian survey 94
Tregs levels and phenotype modifications during Amyotrophic Lateral Sclerosis course 94
Predictors from systemic and neuro-inflammation in amyotrophic lateral sclerosis: A monocentric experience 71
Circulating Serum Cell-Free Mitochondrial DNA in Amyotrophic Lateral Sclerosis 55
Totale 8.871
Categoria #
all - tutte 36.681
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.681


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021108 0 0 0 0 0 0 0 0 0 51 33 24
2021/2022453 40 32 19 13 11 23 13 14 73 50 104 61
2022/2023553 63 71 29 51 67 73 9 54 64 15 27 30
2023/2024565 11 15 36 44 69 30 83 65 13 38 58 103
2024/20252.269 53 24 59 182 357 320 150 86 285 124 280 349
2025/20264.191 440 247 398 545 561 211 565 308 449 467 0 0
Totale 8.871